Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update – The User’s Guide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update – The User’s Guide

Published:2020-10 Issue:7 Volume:44 Page:592-596
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Senior Peter A.,Houlden Robyn L.,Kim James,Mackay Dylan,Nagpal Seema,Rabi Doreen,Sherifali Diana,Bajaj Harpreet S.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada;Can J Diabetes,2018

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

4. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes;Diabetes Care,2016

5. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance;Diabetologia,1991

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study;Diabetes, Obesity and Metabolism;2024-08-07

2. Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study;Canadian Journal of Diabetes;2023-07

3. Diagnosis and Non-Invasive Treatment of Obesity in Adults with Type 2 Diabetes Mellitus: A Review of Guidelines;Journal of Clinical Medicine;2023-06-30

4. Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled Trial;Journal of Diabetes Science and Technology;2023-05-25

5. Care Endpoints in Adults With Type 2 Diabetes: Screening and Therapeutic Targets at a Canadian Tertiary Diabetes Care Centre;Canadian Journal of Diabetes;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3